An updated histological classification system for multiple sclerosis lesions.

Area of Science:

• Neuropathology
• Neuroimmunology
• Central Nervous System (CNS) Diseases

Background:

• Multiple sclerosis (MS) is a complex autoimmune demyelinating disease of the CNS.
• Existing histological classification systems for MS lesions lack uniformity, hindering comparative research.
• A standardized classification is crucial for understanding MS pathogenesis and comparing study findings.

Purpose of the Study:

• To propose a simple, unifying histological classification system for MS lesions.
• To provide guidelines for neuropathologists and researchers studying MS tissue.
• To facilitate better comparison of studies and advance understanding of MS pathogenesis.

Main Methods:

• Classification based on macrophage/microglia presence (inflammatory activity) and demyelination status.
• Differentiating active, mixed active/inactive, and inactive lesions.
• Subdividing active/mixed lesions into demyelinating and post-demyelinating types based on myelin degradation products.
• Utilizing histological stains (e.g., luxol fast blue-PAS) and immunohistochemistry (e.g., anti-CD68, anti-MBP, anti-PLP) for myelin and macrophage identification.

Main Results:

• Proposed classification categorizes MS lesions into active, mixed active/inactive, and inactive.
• Further subdivision into demyelinating (ongoing myelin destruction) and post-demyelinating (ceased destruction) lesions.
• Distinction between early and late demyelinating lesions based on specific myelin protein presence in macrophages.

Conclusions:

• The proposed histological classification offers a standardized approach to analyzing MS lesions.
• This system aids in comparing diverse MS studies and understanding disease mechanisms.
• The classification incorporates inflammatory and demyelinating activity for comprehensive lesion characterization.